<?xml version="1.0" encoding="utf-8"?>
<feed xmlns:dc="http://dublincore.org/documents/dcmi-namespace/" xmlns:media="http://search.yahoo.com/mrss/" xmlns="http://www.w3.org/2005/Atom">
  <title
    type="text">NeutriSci International</title>
  <subtitle
    type="text">Contains the last 20 releases</subtitle>
  <id>uuid:9a2b0997-5a79-4ac2-a515-502ed2bd176a;id=19136</id>
  <rights
    type="text">Copyright 2018, NeutriSci International</rights>
  <updated>2018-03-01T13:00:00Z</updated>
  <author>
    <name>newsdesk@globenewswire.com (NewsDesk)</name>
    <uri>http://www.globenewswire.com/LegacyRss?Length=4</uri>
    <email>newsdesk@globenewswire.com</email>
  </author>
  <link
    rel="alternate"
    href="https://www.globenewswire.com/atomfeed/organization/wibcddGWAfaXDDlEKUaMcQ==" />
  <link
    rel="self"
    href="https://www.globenewswire.com/atomfeed/organization/wibcddGWAfaXDDlEKUaMcQ==" />
  <entry>
    <id>https://www.globenewswire.com/news-release/2018/03/01/1402132/0/en/NeutriSci-Files-Patent-Application.html</id>
    <title
      type="text">NeutriSci Files Patent Application</title>
    <published>2018-03-01T13:00:00Z</published>
    <updated>2024-11-25T05:21:55Z</updated>
    <link
      rel="alternate"
      href="https://www.globenewswire.com/news-release/2018/03/01/1402132/0/en/NeutriSci-Files-Patent-Application.html" />
    <category
      term="TSX-V:NU"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="Other OTC:NRXCF"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="Frankfurt:1N9"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="CA64129Y1079"
      scheme="https://www.globenewswire.com/rss/ISIN" />
    <content
      type="html"><![CDATA[<p>VANCOUVER, British Columbia, March  01, 2018  (GLOBE NEWSWIRE) -- NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX-V:NU) (OTCQB:NRXCF) (FRANKFURT:1N9) the innovator and pioneer behind neuenergy<sup>®</sup>, is pleased to announce the filing of a new U.S. provisional patent application (United States Provisional Patent No. 62/628,735; Compositions Comprising Co-crystals of Stilbenoids and Cannabinoids) relating to compositions comprising pterostilbene and other stilbenoids in formulations which improve the dissolution rate and bioavailability of cannabinoid compounds. </p>]]></content>
    <dc:identifier>1402132</dc:identifier>
    <dc:language>en</dc:language>
    <dc:publisher>GlobeNewswire Inc.</dc:publisher>
    <dc:contributor>NeutriSci International</dc:contributor>
    <dc:modified>Thu, 01 Mar 2018 13:01 GMT</dc:modified>
    <dc:subject>Health</dc:subject>
    <dc:subject>Patents</dc:subject>
  </entry>
  <entry>
    <id>https://www.globenewswire.com/news-release/2018/02/26/1387338/0/en/NeutriSci-and-Lexaria-Bioscience-Enter-Global-Licensing-Agreement.html</id>
    <title
      type="text">NeutriSci and Lexaria Bioscience Enter Global Licensing Agreement</title>
    <published>2018-02-26T13:30:00Z</published>
    <updated>2024-11-25T05:21:55Z</updated>
    <link
      rel="alternate"
      href="https://www.globenewswire.com/news-release/2018/02/26/1387338/0/en/NeutriSci-and-Lexaria-Bioscience-Enter-Global-Licensing-Agreement.html" />
    <category
      term="TSX-V:NU"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="Other OTC:NRXCF"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="Frankfurt:1N9"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="CA64129Y1079"
      scheme="https://www.globenewswire.com/rss/ISIN" />
    <content
      type="html"><![CDATA[<p align="justify">VANCOUVER, British Columbia, Feb.  26, 2018  (GLOBE NEWSWIRE) -- NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX-V:NU) (OTCQB:NRXCF) (Frankfurt:1N9) and Lexaria Bioscience Corp. (“Lexaria”) (CSE:LXX) (OTCQX:LXRP) are pleased to announce that they have revised their joint venture agreement such that NeutriSci now owns 100% of Ambarii Trade Corporation (“Ambarii”), and Lexaria has granted to NeutriSci, an Intellectual Property License and Supply Agreement (the “License Agreement”) for the manufacturing and sale of CBD based products.<br></p>]]></content>
    <dc:identifier>1387338</dc:identifier>
    <dc:language>en</dc:language>
    <dc:publisher>GlobeNewswire Inc.</dc:publisher>
    <dc:contributor>NeutriSci International</dc:contributor>
    <dc:modified>Mon, 26 Feb 2018 13:30 GMT</dc:modified>
    <dc:subject>Licensing Agreements</dc:subject>
  </entry>
  <entry>
    <id>https://www.globenewswire.com/news-release/2018/02/22/1379917/0/en/NeutriSci-Named-to-the-2018-TSX-Venture-50.html</id>
    <title
      type="text">NeutriSci Named to the 2018 TSX Venture 50®</title>
    <published>2018-02-22T13:30:00Z</published>
    <updated>2024-11-25T05:21:55Z</updated>
    <link
      rel="alternate"
      href="https://www.globenewswire.com/news-release/2018/02/22/1379917/0/en/NeutriSci-Named-to-the-2018-TSX-Venture-50.html" />
    <category
      term="TSX-V:NU"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="Other OTC:NRXCF"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="Frankfurt:1N9"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="CA64129Y1079"
      scheme="https://www.globenewswire.com/rss/ISIN" />
    <content
      type="html"><![CDATA[<p align="left">VANCOUVER, B.C., Feb.  22, 2018  (GLOBE NEWSWIRE) -- NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX-V:NU) (OTCQB:NRXCF) (Frankfurt:1N9) is pleased to announce it has been named to the 2018 TSX Venture 50<sup>®</sup>, an annual ranking of top-performing companies on the TSX Venture Exchange over the last year, ranking 10th overall.<br></p>]]></content>
    <dc:identifier>1379917</dc:identifier>
    <dc:language>en</dc:language>
    <dc:publisher>GlobeNewswire Inc.</dc:publisher>
    <dc:contributor>NeutriSci International</dc:contributor>
    <dc:modified>Thu, 22 Feb 2018 13:31 GMT</dc:modified>
    <dc:subject>Company Announcement</dc:subject>
  </entry>
  <entry>
    <id>https://www.globenewswire.com/news-release/2018/01/11/1354132/0/en/NeutriSci-Announces-Major-Sponsorship-With-Tennis-Star-Genie-Bouchard.html</id>
    <title
      type="text">NeutriSci Announces Major Sponsorship With Tennis Star Genie Bouchard</title>
    <published>2018-01-11T13:30:00Z</published>
    <updated>2024-11-25T05:21:55Z</updated>
    <link
      rel="alternate"
      href="https://www.globenewswire.com/news-release/2018/01/11/1354132/0/en/NeutriSci-Announces-Major-Sponsorship-With-Tennis-Star-Genie-Bouchard.html" />
    <category
      term="TSX-V:NU"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="Other OTC:NRXCF"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="Frankfurt:1N9"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="CA64129Y1079"
      scheme="https://www.globenewswire.com/rss/ISIN" />
    <content
      type="html"><![CDATA[<p><span class="mw_region">VANCOUVER, BC</span><span>--(Marketwired - January 11, 2018) - </span> NeutriSci International Inc. (the "Company" or "NeutriSci") (<exchange name="TSX VENTURE">TSX VENTURE</exchange>: <ticker name="NU">NU</ticker>) (<exchange name="OTCQB">OTCQB</exchange>: <ticker name="NRXCF">NRXCF</ticker>) (<exchange name="FRANKFURT">FRANKFURT</exchange>: <ticker name="1N9">1N9</ticker>), the innovator and pioneer behind neuenergy<sup>®</sup>, is pleased to announce a one-year sponsorship deal with Canadian and International tennis star Genie Bouchard, from Montreal, Quebec. </p>]]></content>
    <dc:identifier>1354132</dc:identifier>
    <dc:language>en</dc:language>
    <dc:publisher>GlobeNewswire Inc.</dc:publisher>
    <dc:contributor>NeutriSci International</dc:contributor>
    <dc:modified>Fri, 16 Feb 2018 04:16 GMT</dc:modified>
  </entry>
  <entry>
    <id>https://www.globenewswire.com/news-release/2017/11/06/1354130/0/en/NeutriSci-Announces-Pending-Approval-From-Japanese-Government-for-Distribution-of-CBD-Products-Through-Naturally-Splendid.html</id>
    <title
      type="text">NeutriSci Announces Pending Approval From Japanese Government for Distribution of CBD Products Through Naturally Splendid</title>
    <published>2017-11-06T13:00:00Z</published>
    <updated>2024-11-25T05:21:55Z</updated>
    <link
      rel="alternate"
      href="https://www.globenewswire.com/news-release/2017/11/06/1354130/0/en/NeutriSci-Announces-Pending-Approval-From-Japanese-Government-for-Distribution-of-CBD-Products-Through-Naturally-Splendid.html" />
    <category
      term="TSX-V:NU"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="Other OTC:NRXCF"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="Frankfurt:1N9"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="CA64129Y1079"
      scheme="https://www.globenewswire.com/rss/ISIN" />
    <content
      type="html"><![CDATA[<p><span class="mw_region">VANCOUVER, BC</span><span>--(Marketwired - November 06, 2017) - </span> NeutriSci International Inc. (the "Company" or "NeutriSci") (<exchange name="TSX VENTURE">TSX VENTURE</exchange>: <ticker name="NU">NU</ticker>) (<exchange name="OTCQB">OTCQB</exchange>: <ticker name="NRXCF">NRXCF</ticker>) (<exchange name="FRANKFURT">FRANKFURT</exchange>: <ticker name="1N9">1N9</ticker>), the innovator and pioneer behind neuenergy<sup>®</sup>, is pleased to announce that its partner in Japan and South Korea for Ambarii Corporation ("Ambarii") CBD products, Naturally Splendid USA ("Naturally Splendid"), expects final approval imminently from the Japanese government for distribution of CBD products in Japan. </p>]]></content>
    <dc:identifier>1354130</dc:identifier>
    <dc:language>en</dc:language>
    <dc:publisher>GlobeNewswire Inc.</dc:publisher>
    <dc:contributor>NeutriSci International</dc:contributor>
    <dc:modified>Fri, 16 Feb 2018 04:16 GMT</dc:modified>
  </entry>
  <entry>
    <id>https://www.globenewswire.com/news-release/2017/07/20/1354128/0/en/NeutriSci-s-Neuenergy-R-Launches-in-Quebec.html</id>
    <title
      type="text">NeutriSci's Neuenergy(R) Launches in Quebec</title>
    <published>2017-07-20T12:00:00Z</published>
    <updated>2024-11-25T05:21:55Z</updated>
    <link
      rel="alternate"
      href="https://www.globenewswire.com/news-release/2017/07/20/1354128/0/en/NeutriSci-s-Neuenergy-R-Launches-in-Quebec.html" />
    <category
      term="TSX-V:NU"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="Other OTC:NRXCF"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="Frankfurt:1N9"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="CA64129Y1079"
      scheme="https://www.globenewswire.com/rss/ISIN" />
    <content
      type="html"><![CDATA[<p><span class="mw_region">VANCOUVER, BC</span><span>--(Marketwired - July 20, 2017) - </span> NeutriSci International Inc. (the "Company" or "NeutriSci") (<exchange name="TSX VENTURE">TSX VENTURE</exchange>: <ticker name="NU">NU</ticker>) (<exchange name="OTCQB">OTCQB</exchange>: <ticker name="NRXCF">NRXCF</ticker>) (<exchange name="FRANKFURT">FRANKFURT</exchange>: <ticker name="1N9">1N9</ticker>) the innovator and pioneer behind neuenergy<sup>®</sup>, is pleased to announce that neuenergy® is now available at Sobeys gas bars and convenience stores in Quebec. </p>]]></content>
    <dc:identifier>1354128</dc:identifier>
    <dc:language>en</dc:language>
    <dc:publisher>GlobeNewswire Inc.</dc:publisher>
    <dc:contributor>NeutriSci International</dc:contributor>
    <dc:modified>Fri, 16 Feb 2018 04:16 GMT</dc:modified>
  </entry>
  <entry>
    <id>https://www.globenewswire.com/news-release/2017/07/07/1354126/0/en/NeutriSci-Announces-Warrant-Incentive-Program.html</id>
    <title
      type="text">NeutriSci Announces Warrant Incentive Program</title>
    <published>2017-07-07T15:47:33Z</published>
    <updated>2024-11-25T05:21:55Z</updated>
    <link
      rel="alternate"
      href="https://www.globenewswire.com/news-release/2017/07/07/1354126/0/en/NeutriSci-Announces-Warrant-Incentive-Program.html" />
    <category
      term="TSX-V:NU"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="Other OTC:NRXCF"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="Frankfurt:1N9"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="CA64129Y1079"
      scheme="https://www.globenewswire.com/rss/ISIN" />
    <content
      type="html"><![CDATA[<p><span class="mw_region">VANCOUVER, BC</span><span>--(Marketwired - July 07, 2017) - </span> NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9), the innovator and pioneer behind neuenergy<sup>®</sup>, is pleased to announce that it will immediately implement an incentive program designed to encourage the early exercise of up to 1,722,333 warrants issued on September 30, 2015 (the "<strong>September 2015 Warrants</strong>"); and 13,013,000 warrants issued on November 25, 2015 (the "<strong>November</strong> <strong>2015</strong> <strong>Warrants</strong>"); and the exercise of up to 2,220,000 warrants issued on July 25, 2016 (the "<strong>July 2016</strong> <strong>Warrants</strong>"); and the exercise of up to 1,667,000 warrants issued on September 30, 2016 (the "<strong>September 2016 Warrants</strong>"); and the exercise of up to 15,000,000 warrants issued on November 18, 2016 (the "<strong>November</strong> <strong>2016</strong> <strong>Warrants</strong>"); and the exercise of up to 3,333,000 warrants issued on May 2, 2017 (the "<strong>May 2017 Warrants</strong>" and together with the September 2015, November 2015, July 2016, September 2016, and November 2016 Warrants, the "<strong>Original Warrants</strong>"). </p>]]></content>
    <dc:identifier>1354126</dc:identifier>
    <dc:language>en</dc:language>
    <dc:publisher>GlobeNewswire Inc.</dc:publisher>
    <dc:contributor>NeutriSci International</dc:contributor>
    <dc:modified>Fri, 16 Feb 2018 04:16 GMT</dc:modified>
  </entry>
  <entry>
    <id>https://www.globenewswire.com/news-release/2017/06/06/1354120/0/en/NeutriSci-Announces-International-Distribution-Agreement-and-Initial-Orders-Into-China-Hong-Kong-Taiwan-and-Macau.html</id>
    <title
      type="text">NeutriSci Announces International Distribution Agreement and Initial Orders Into China, Hong Kong, Taiwan and Macau</title>
    <published>2017-06-06T12:30:00Z</published>
    <updated>2024-11-25T05:21:55Z</updated>
    <link
      rel="alternate"
      href="https://www.globenewswire.com/news-release/2017/06/06/1354120/0/en/NeutriSci-Announces-International-Distribution-Agreement-and-Initial-Orders-Into-China-Hong-Kong-Taiwan-and-Macau.html" />
    <category
      term="TSX-V:NU"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="Other OTC:NRXCF"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="Frankfurt:1N9"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="CA64129Y1079"
      scheme="https://www.globenewswire.com/rss/ISIN" />
    <content
      type="html"><![CDATA[<p><span class="mw_region">VANCOUVER, BC</span><span>--(Marketwired - June 06, 2017) - </span> NeutriSci International Inc. (the "Company" or "NeutriSci") (<exchange name="TSX VENTURE">TSX VENTURE</exchange>: <ticker name="NU">NU</ticker>) (<exchange name="OTCQB">OTCQB</exchange>: <ticker name="NRXCF">NRXCF</ticker>) (<exchange name="FRANKFURT">FRANKFURT</exchange>: <ticker name="1N9">1N9</ticker>), the innovator and pioneer behind neuenergy<sup>®</sup>, is pleased to announce its first major distribution agreement for neuenergy<sup>®</sup> into Greater China including Mainland China, Hong Kong, Taiwan and Macau. </p>]]></content>
    <dc:identifier>1354120</dc:identifier>
    <dc:language>en</dc:language>
    <dc:publisher>GlobeNewswire Inc.</dc:publisher>
    <dc:contributor>NeutriSci International</dc:contributor>
    <dc:modified>Fri, 16 Feb 2018 04:16 GMT</dc:modified>
  </entry>
  <entry>
    <id>https://www.globenewswire.com/news-release/2017/06/01/1354117/0/en/NeutriSci-Adds-Esso-Gas-Bars-and-Convenience-Stores-to-Its-List-of-Canadian-Retailers.html</id>
    <title
      type="text">NeutriSci Adds Esso Gas Bars and Convenience Stores to Its List of Canadian Retailers</title>
    <published>2017-06-01T12:30:00Z</published>
    <updated>2024-11-25T05:21:55Z</updated>
    <link
      rel="alternate"
      href="https://www.globenewswire.com/news-release/2017/06/01/1354117/0/en/NeutriSci-Adds-Esso-Gas-Bars-and-Convenience-Stores-to-Its-List-of-Canadian-Retailers.html" />
    <category
      term="TSX-V:NU"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="Other OTC:NRXCF"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="Frankfurt:1N9"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="CA64129Y1079"
      scheme="https://www.globenewswire.com/rss/ISIN" />
    <content
      type="html"><![CDATA[<p><span class="mw_region">VANCOUVER, BC</span><span>--(Marketwired - June 01, 2017) - </span>NeutriSci International Inc. (the "Company" or "NeutriSci") (<exchange name="TSX VENTURE">TSX VENTURE</exchange>: <ticker name="NU">NU</ticker>) (<exchange name="OTCQB">OTCQB</exchange>: <ticker name="NRXCF">NRXCF</ticker>) (<exchange name="FRANKFURT">FRANKFURT</exchange>: <ticker name="1N9">1N9</ticker>) the innovator and pioneer behind neuenergy<sup>®</sup>, announces its latest distribution agreement with Esso gas bars and convenience stores representing 150 stores in Saskatchewan, Alberta and British Columbia.</p>]]></content>
    <dc:identifier>1354117</dc:identifier>
    <dc:language>en</dc:language>
    <dc:publisher>GlobeNewswire Inc.</dc:publisher>
    <dc:contributor>NeutriSci International</dc:contributor>
    <dc:modified>Fri, 16 Feb 2018 04:16 GMT</dc:modified>
  </entry>
  <entry>
    <id>https://www.globenewswire.com/news-release/2017/05/30/1354112/0/en/NeutriSci-s-Ambarii-Corporation-Announces-LOI-With-Naturally-Splendid-to-Distribute-CBD-Melts-in-Japan-and-South-Korea.html</id>
    <title
      type="text">NeutriSci's Ambarii Corporation Announces LOI With Naturally Splendid to Distribute CBD Melts in Japan and South Korea</title>
    <published>2017-05-30T12:00:00Z</published>
    <updated>2024-11-25T05:21:55Z</updated>
    <link
      rel="alternate"
      href="https://www.globenewswire.com/news-release/2017/05/30/1354112/0/en/NeutriSci-s-Ambarii-Corporation-Announces-LOI-With-Naturally-Splendid-to-Distribute-CBD-Melts-in-Japan-and-South-Korea.html" />
    <category
      term="TSX-V:NU"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="Other OTC:NRXCF"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="Frankfurt:1N9"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="CA64129Y1079"
      scheme="https://www.globenewswire.com/rss/ISIN" />
    <content
      type="html"><![CDATA[<p><span class="mw_region">VANCOUVER, BC</span><span>--(Marketwired - May 30, 2017) - </span> NeutriSci International Inc. (the "Company" or "NeutriSci") (<exchange name="TSX VENTURE">TSX VENTURE</exchange>: <ticker name="NU">NU</ticker>) (<exchange name="OTCQB">OTCQB</exchange>: <ticker name="NRXCF">NRXCF</ticker>) (<exchange name="FRANKFURT">FRANKFURT</exchange>: <ticker name="1N9">1N9</ticker>) is pleased to announce that its joint venture subsidiary, Ambarii Trade Corporation ("Ambarii") and Naturally Splendid Enterprises Ltd. ("Naturally Splendid") have entered into a LOI for the sale and distribution of Ambarii's proprietary sublingual full spectrum hemp CBD tablets ("Ambarii CBD Tablets") in Japan and South Korea. </p>]]></content>
    <dc:identifier>1354112</dc:identifier>
    <dc:language>en</dc:language>
    <dc:publisher>GlobeNewswire Inc.</dc:publisher>
    <dc:contributor>NeutriSci International</dc:contributor>
    <dc:modified>Fri, 16 Feb 2018 04:16 GMT</dc:modified>
  </entry>
  <entry>
    <id>https://www.globenewswire.com/news-release/2017/05/02/1354108/0/en/NeutriSci-Completes-Private-Placement.html</id>
    <title
      type="text">NeutriSci Completes Private Placement</title>
    <published>2017-05-02T20:35:44Z</published>
    <updated>2024-11-25T05:21:55Z</updated>
    <link
      rel="alternate"
      href="https://www.globenewswire.com/news-release/2017/05/02/1354108/0/en/NeutriSci-Completes-Private-Placement.html" />
    <category
      term="TSX-V:NU"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="Other OTC:NRXCF"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="Frankfurt:1N9"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="CA64129Y1079"
      scheme="https://www.globenewswire.com/rss/ISIN" />
    <content
      type="html"><![CDATA[<p align="left"> <span class="mw_region">VANCOUVER, BC</span><span>--(Marketwired - May 02, 2017) - </span> NeutriSci International Inc. (the "Company" or "NeutriSci") (<exchange name="TSX VENTURE">TSX VENTURE</exchange>: <ticker name="NU">NU</ticker>) (<exchange name="OTCQB">OTCQB</exchange>: <ticker name="NRXCF">NRXCF</ticker>) (<exchange name="FRANKFURT">FRANKFURT</exchange>: <ticker name="1N9">1N9</ticker>) is pleased to announce that it has completed a non-brokered private placement (the "Placement") in which it raised gross proceeds of $399,960.</p>]]></content>
    <dc:identifier>1354108</dc:identifier>
    <dc:language>en</dc:language>
    <dc:publisher>GlobeNewswire Inc.</dc:publisher>
    <dc:contributor>NeutriSci International</dc:contributor>
    <dc:modified>Fri, 16 Feb 2018 04:16 GMT</dc:modified>
  </entry>
  <entry>
    <id>https://www.globenewswire.com/news-release/2017/04/10/1354104/0/en/NeutriSci-Forms-Cannabinoid-Joint-Venture-With-Lexaria-Bioscience.html</id>
    <title
      type="text">NeutriSci Forms Cannabinoid Joint Venture With Lexaria Bioscience</title>
    <published>2017-04-10T12:30:00Z</published>
    <updated>2024-11-25T05:21:55Z</updated>
    <link
      rel="alternate"
      href="https://www.globenewswire.com/news-release/2017/04/10/1354104/0/en/NeutriSci-Forms-Cannabinoid-Joint-Venture-With-Lexaria-Bioscience.html" />
    <category
      term="TSX-V:NU"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="Other OTC:NRXCF"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="Frankfurt:1N9"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="CA64129Y1079"
      scheme="https://www.globenewswire.com/rss/ISIN" />
    <content
      type="html"><![CDATA[<p><span class="mw_region">VANCOUVER, BC</span><span>--(Marketwired - April 10, 2017) - </span> NeutriSci International Inc. (the "Company" or "NeutriSci") (<exchange name="TSX VENTURE">TSX VENTURE</exchange>: <ticker name="NU">NU</ticker>) (<exchange name="OTCQB">OTCQB</exchange>: <ticker name="NRXCF">NRXCF</ticker>) (<exchange name="FRANKFURT">FRANKFURT</exchange>: <ticker name="1N9">1N9</ticker>) and Lexaria Bioscience Corp. ("Lexaria") (<exchange name="CSE">CSE</exchange>: <ticker name="LXX">LXX</ticker>) (<exchange name="OTCQB">OTCQB</exchange>: <ticker name="LXRP">LXRP</ticker>) are pleased to announce finalization of the joint venture between the companies to produce and commercialize a line of healthy, sugar-free, edible cannabinoid sublingual tablets combining NeutriSci's proprietary pterostilbene tablet form factor and Lexaria's patented technology. </p>]]></content>
    <dc:identifier>1354104</dc:identifier>
    <dc:language>en</dc:language>
    <dc:publisher>GlobeNewswire Inc.</dc:publisher>
    <dc:contributor>NeutriSci International</dc:contributor>
    <dc:modified>Fri, 16 Feb 2018 04:16 GMT</dc:modified>
  </entry>
  <entry>
    <id>https://www.globenewswire.com/news-release/2017/03/30/1354100/0/en/NeutriSci-Welcomes-Olympic-Gold-Medalists-Michelle-Cameron-Coulter-and-Al-Coulter-as-Neuenergy-Brand-Ambassadors.html</id>
    <title
      type="text">NeutriSci Welcomes Olympic Gold Medalists Michelle Cameron Coulter and Al Coulter as Neuenergy Brand Ambassadors</title>
    <published>2017-03-30T12:30:00Z</published>
    <updated>2024-11-25T05:21:55Z</updated>
    <link
      rel="alternate"
      href="https://www.globenewswire.com/news-release/2017/03/30/1354100/0/en/NeutriSci-Welcomes-Olympic-Gold-Medalists-Michelle-Cameron-Coulter-and-Al-Coulter-as-Neuenergy-Brand-Ambassadors.html" />
    <category
      term="TSX-V:NU"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="Other OTC:NRXCF"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="Frankfurt:1N9"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="CA64129Y1079"
      scheme="https://www.globenewswire.com/rss/ISIN" />
    <content
      type="html"><![CDATA[<p><span class="mw_region">VANCOUVER, BC</span><span>--(Marketwired - March 30, 2017) - </span> NeutriSci International Inc. (the "Company" or "NeutriSci") (<exchange name="TSX VENTURE">TSX VENTURE</exchange>: <ticker name="NU">NU</ticker>) (<exchange name="OTCQB">OTCQB</exchange>: <ticker name="NRXCF">NRXCF</ticker>) (<exchange name="FRANKFURT">FRANKFURT</exchange>: <ticker name="1N9">1N9</ticker>) the innovator and pioneer behind neuenergy<sup>®</sup>, is pleased to announce the addition of Olympic Gold medalists Michelle Cameron Coulter and Al Coulter to the Company's neuenergy<sup>®</sup> Ambassador Marketing Program ("NAMP").</p>]]></content>
    <dc:identifier>1354100</dc:identifier>
    <dc:language>en</dc:language>
    <dc:publisher>GlobeNewswire Inc.</dc:publisher>
    <dc:contributor>NeutriSci International</dc:contributor>
    <dc:modified>Fri, 16 Feb 2018 04:16 GMT</dc:modified>
  </entry>
  <entry>
    <id>https://www.globenewswire.com/news-release/2017/03/29/1354096/0/en/NeutriSci-Announces-Advanced-Talks-With-Several-of-Canada-s-Leading-Medical-Marijuana-Companies.html</id>
    <title
      type="text">NeutriSci Announces Advanced Talks With Several of Canada's Leading Medical Marijuana Companies</title>
    <published>2017-03-29T12:30:00Z</published>
    <updated>2024-11-25T05:21:55Z</updated>
    <link
      rel="alternate"
      href="https://www.globenewswire.com/news-release/2017/03/29/1354096/0/en/NeutriSci-Announces-Advanced-Talks-With-Several-of-Canada-s-Leading-Medical-Marijuana-Companies.html" />
    <category
      term="TSX-V:NU"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="Other OTC:NRXCF"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="Frankfurt:1N9"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="CA64129Y1079"
      scheme="https://www.globenewswire.com/rss/ISIN" />
    <content
      type="html"><![CDATA[<p><span class="mw_region">VANCOUVER, BC</span><span>--(Marketwired - March 29, 2017) - </span> NeutriSci International Inc. (the "Company" or "NeutriSci") (<exchange name="TSX VENTURE">TSX VENTURE</exchange>: <ticker name="NU">NU</ticker>) (<exchange name="OTCQB">OTCQB</exchange>: <ticker name="NRXCF">NRXCF</ticker>) (<exchange name="FRANKFURT">FRANKFURT</exchange>: <ticker name="1N9">1N9</ticker>) the innovator and pioneer behind neuenergy<sup>®</sup>, confirms it is in advanced discussions regarding product formulation with several of the top companies in Canada's burgeoning cannabis sector.</p>]]></content>
    <dc:identifier>1354096</dc:identifier>
    <dc:language>en</dc:language>
    <dc:publisher>GlobeNewswire Inc.</dc:publisher>
    <dc:contributor>NeutriSci International</dc:contributor>
    <dc:modified>Fri, 16 Feb 2018 04:16 GMT</dc:modified>
  </entry>
  <entry>
    <id>https://www.globenewswire.com/news-release/2017/03/21/1354092/0/en/NeutriSci-Announces-Launch-of-New-Ambassador-Direct-Sales-Channel.html</id>
    <title
      type="text">NeutriSci Announces Launch of New Ambassador Direct Sales Channel</title>
    <published>2017-03-21T12:30:00Z</published>
    <updated>2024-11-25T05:21:55Z</updated>
    <link
      rel="alternate"
      href="https://www.globenewswire.com/news-release/2017/03/21/1354092/0/en/NeutriSci-Announces-Launch-of-New-Ambassador-Direct-Sales-Channel.html" />
    <category
      term="TSX-V:NU"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="Other OTC:NRXCF"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="Frankfurt:1N9"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="CA64129Y1079"
      scheme="https://www.globenewswire.com/rss/ISIN" />
    <content
      type="html"><![CDATA[<p><span class="mw_region">VANCOUVER, BC</span><span>--(Marketwired - March 21, 2017) - </span> NeutriSci International Inc. (the "Company" or "NeutriSci") (<exchange name="TSX VENTURE">TSX VENTURE</exchange>: <ticker name="NU">NU</ticker>) (<exchange name="OTCQB">OTCQB</exchange>: <ticker name="NRXCF">NRXCF</ticker>) (<exchange name="FRANKFURT">FRANKFURT</exchange>: <ticker name="1N9">1N9</ticker>) the innovator and pioneer behind neuenergy<sup>®</sup>, is pleased to announce the launch of its ambassador marketing program for neuenergy<sup>®</sup>.</p>]]></content>
    <dc:identifier>1354092</dc:identifier>
    <dc:language>en</dc:language>
    <dc:publisher>GlobeNewswire Inc.</dc:publisher>
    <dc:contributor>NeutriSci International</dc:contributor>
    <dc:modified>Fri, 16 Feb 2018 04:16 GMT</dc:modified>
  </entry>
  <entry>
    <id>https://www.globenewswire.com/news-release/2017/03/16/1354087/0/en/NeutriSci-Announces-Distribution-Agreement-Initial-Order-of-Neuenergy-From-Gateway-Newstands.html</id>
    <title
      type="text">NeutriSci Announces Distribution Agreement &amp; Initial Order of Neuenergy From Gateway Newstands</title>
    <published>2017-03-16T12:30:00Z</published>
    <updated>2024-11-25T05:21:55Z</updated>
    <link
      rel="alternate"
      href="https://www.globenewswire.com/news-release/2017/03/16/1354087/0/en/NeutriSci-Announces-Distribution-Agreement-Initial-Order-of-Neuenergy-From-Gateway-Newstands.html" />
    <category
      term="TSX-V:NU"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="Other OTC:NRXCF"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="Frankfurt:1N9"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="CA64129Y1079"
      scheme="https://www.globenewswire.com/rss/ISIN" />
    <content
      type="html"><![CDATA[<p align="left"> <span class="mw_region">VANCOUVER, BC</span><span>--(Marketwired - March 16, 2017) - </span> NeutriSci International Inc. (the "Company" or "NeutriSci") (<exchange name="TSX VENTURE">TSX VENTURE</exchange>: <ticker name="NU">NU</ticker>) (<exchange name="OTCQB">OTCQB</exchange>: <ticker name="NRXCF">NRXCF</ticker>) (<exchange name="FRANKFURT">FRANKFURT</exchange>: <ticker name="1N9">1N9</ticker>) the innovator and pioneer behind neuenergy<sup>®</sup>, is pleased to announce that neuenergy<sup>® </sup>is now available at Gateway Newstands across Canada and the United States.</p>]]></content>
    <dc:identifier>1354087</dc:identifier>
    <dc:language>en</dc:language>
    <dc:publisher>GlobeNewswire Inc.</dc:publisher>
    <dc:contributor>NeutriSci International</dc:contributor>
    <dc:modified>Fri, 16 Feb 2018 04:16 GMT</dc:modified>
  </entry>
  <entry>
    <id>https://www.globenewswire.com/news-release/2017/03/09/1354083/0/en/NeutriSci-Launches-National-Television-Ad-Campaign.html</id>
    <title
      type="text">NeutriSci Launches National Television Ad Campaign</title>
    <published>2017-03-09T13:30:00Z</published>
    <updated>2024-11-25T05:21:55Z</updated>
    <link
      rel="alternate"
      href="https://www.globenewswire.com/news-release/2017/03/09/1354083/0/en/NeutriSci-Launches-National-Television-Ad-Campaign.html" />
    <category
      term="TSX-V:NU"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="Other OTC:NRXCF"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="Frankfurt:1N9"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="CA64129Y1079"
      scheme="https://www.globenewswire.com/rss/ISIN" />
    <content
      type="html"><![CDATA[<p><span class="mw_region">VANCOUVER, BC</span><span>--(Marketwired - March 09, 2017) - </span> NeutriSci International Inc. (the "Company" or "NeutriSci") (<exchange name="TSX VENTURE">TSX VENTURE</exchange>: <ticker name="NU">NU</ticker>) (<exchange name="OTCQB">OTCQB</exchange>: <ticker name="NRXCF">NRXCF</ticker>) (<exchange name="FRANKFURT">FRANKFURT</exchange>: <ticker name="1N9">1N9</ticker>) the innovator and pioneer behind neuenergy®, is pleased to announce the launch of its national television campaign for neuenergy®. </p>]]></content>
    <dc:identifier>1354083</dc:identifier>
    <dc:language>en</dc:language>
    <dc:publisher>GlobeNewswire Inc.</dc:publisher>
    <dc:contributor>NeutriSci International</dc:contributor>
    <dc:modified>Fri, 16 Feb 2018 04:16 GMT</dc:modified>
  </entry>
  <entry>
    <id>https://www.globenewswire.com/news-release/2017/03/06/1354080/0/en/NeutriSci-Announces-OTCQB-Listing.html</id>
    <title
      type="text">NeutriSci Announces OTCQB Listing</title>
    <published>2017-03-06T21:43:30Z</published>
    <updated>2024-11-25T05:21:55Z</updated>
    <link
      rel="alternate"
      href="https://www.globenewswire.com/news-release/2017/03/06/1354080/0/en/NeutriSci-Announces-OTCQB-Listing.html" />
    <category
      term="TSX-V:NU"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="Other OTC:NRXCF"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="Frankfurt:1N9"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="CA64129Y1079"
      scheme="https://www.globenewswire.com/rss/ISIN" />
    <content
      type="html"><![CDATA[<p><span class="mw_region">VANCOUVER, BC</span><span>--(Marketwired - March 06, 2017) - </span> NeutriSci International Inc. (the "Company" or "NeutriSci") (<exchange name="TSX VENTURE">TSX VENTURE</exchange>: <ticker name="NU">NU</ticker>) (<exchange name="OTCQB">OTCQB</exchange>: <ticker name="NRXCF">NRXCF</ticker>) (<exchange name="FRANKFURT">FRANKFURT</exchange>: <ticker name="1N9">1N9</ticker>) is pleased to announce that it has commenced trading on the OTCQB Marketplace under the symbol NRXCF. </p>]]></content>
    <dc:identifier>1354080</dc:identifier>
    <dc:language>en</dc:language>
    <dc:publisher>GlobeNewswire Inc.</dc:publisher>
    <dc:contributor>NeutriSci International</dc:contributor>
    <dc:modified>Fri, 16 Feb 2018 04:16 GMT</dc:modified>
  </entry>
  <entry>
    <id>https://www.globenewswire.com/news-release/2017/01/19/1354076/0/en/NeutriSci-Announces-Successful-Development-and-Positive-Results-From-Initial-Observational-Product-Trials-With-Lexaria-Bioscience.html</id>
    <title
      type="text">NeutriSci Announces Successful Development and Positive Results From Initial Observational Product Trials With Lexaria Bioscience</title>
    <published>2017-01-19T13:00:00Z</published>
    <updated>2024-11-25T05:21:55Z</updated>
    <link
      rel="alternate"
      href="https://www.globenewswire.com/news-release/2017/01/19/1354076/0/en/NeutriSci-Announces-Successful-Development-and-Positive-Results-From-Initial-Observational-Product-Trials-With-Lexaria-Bioscience.html" />
    <category
      term="TSX-V:NU"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="Other OTC:NRXCF"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="Frankfurt:1N9"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="CA64129Y1079"
      scheme="https://www.globenewswire.com/rss/ISIN" />
    <content
      type="html"><![CDATA[<p><span class="mw_region">VANCOUVER, BC</span><span>--(Marketwired - January 19, 2017) - </span> NeutriSci International Inc. (the "Company" or "NeutriSci") (<exchange name="TSX VENTURE">TSX VENTURE</exchange>: <ticker name="NU">NU</ticker>) (<exchange name="FRANKFURT">FRANKFURT</exchange>: <ticker name="1N9">1N9</ticker>) and Lexaria Bioscience Corp. ("Lexaria") (<exchange name="CSE">CSE</exchange>: <ticker name="LXX">LXX</ticker>) are pleased to announce the successful development and initial trial of the industry's first cannabinoid / pterostilbene edible tablet utilizing NeutriSci's and Lexaria's proprietary and patented technologies. </p>]]></content>
    <dc:identifier>1354076</dc:identifier>
    <dc:language>en</dc:language>
    <dc:publisher>GlobeNewswire Inc.</dc:publisher>
    <dc:contributor>NeutriSci International</dc:contributor>
    <dc:modified>Fri, 16 Feb 2018 04:16 GMT</dc:modified>
  </entry>
  <entry>
    <id>https://www.globenewswire.com/news-release/2017/01/17/1354072/0/en/NeutriSci-Adds-Sobeys-Safeway-to-Its-List-of-Canadian-Retailers.html</id>
    <title
      type="text">NeutriSci Adds Sobeys &amp; Safeway to Its List of Canadian Retailers</title>
    <published>2017-01-17T13:30:00Z</published>
    <updated>2024-11-25T05:21:55Z</updated>
    <link
      rel="alternate"
      href="https://www.globenewswire.com/news-release/2017/01/17/1354072/0/en/NeutriSci-Adds-Sobeys-Safeway-to-Its-List-of-Canadian-Retailers.html" />
    <category
      term="TSX-V:NU"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="Other OTC:NRXCF"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="Frankfurt:1N9"
      scheme="https://www.globenewswire.com/rss/stock" />
    <category
      term="CA64129Y1079"
      scheme="https://www.globenewswire.com/rss/ISIN" />
    <content
      type="html"><![CDATA[<p><span class="mw_region">VANCOUVER, BC</span><span>--(Marketwired - January 17, 2017) - </span>NeutriSci International Inc. (the "Company" or "NeutriSci") (<exchange name="TSX VENTURE">TSX VENTURE</exchange>: <ticker name="NU">NU</ticker>) (<exchange name="FRANKFURT">FRANKFURT</exchange>: <ticker name="1N9">1N9</ticker>) the innovator and pioneer behind neuenergy<sup>®</sup>, announces its latest distribution agreement with Sobeys and Safeway Canada.</p>]]></content>
    <dc:identifier>1354072</dc:identifier>
    <dc:language>en</dc:language>
    <dc:publisher>GlobeNewswire Inc.</dc:publisher>
    <dc:contributor>NeutriSci International</dc:contributor>
    <dc:modified>Fri, 16 Feb 2018 04:16 GMT</dc:modified>
  </entry>
</feed>